Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xigris in severe sepsis (Phase IV)
NCT00568893Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of drotrecogin alfa in sepsis, sponsored by Eli Lilly and Company. Started Jan 2003; status: completed.
02
Drugs
drotrecogin alfa
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00568893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568893.